As the world struggles with the ongoing COVID-19 pandemic, unprecedented obstacles
have continuously been traversed as new SARS-CoV-2 variants continually emerge …

The continuous emergence of novel SARS-CoV-2 variants and subvariants serves as
compelling evidence that COVID-19 is an ongoing concern. The swift, well-coordinated …

There is an urgent need to identify new therapies that prevent SARS-CoV-2 infection and
improve the outcome of COVID-19 patients. This pandemic has thus spurred intensive …

Because of its scale and suddenness, the SARS-CoV-2 pandemic has created an
unprecedented challenge in terms of drug development. Apart from being natural …

With more than 5 million fatalities and close to 300 million reported cases, COVID-19 is the
first documented pandemic due to a coronavirus that continues to be a major health …

New variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to
arise and prolong the coronavirus disease 2019 (COVID-19) pandemic. Here, we used a …

On 26 January, Profluent came out of stealth mode with $9 million in seed funding to support
the company's efforts to apply machine learning (ML) to engineer novel functional proteins …

Blocking the association between the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) spike protein receptor-binding domain (RBD) and the human angiotensin …

The COVID-19 pandemic has caused significant social and economic disruption across the
globe. Cellular entry of SARS-CoV-2 into the human body is mediated via binding of the …

The outbreak of COVID-19 has now become a global pandemic and it continues to spread
rapidly worldwide, severely threatening lives and economic stability. Making the problem …